Free Flow Medical, Inc. reported raising $2.82 Million in an initial SEC Form D filing, from an offering of $4.1 Million
PRIVATEMar 11, 2019$2.8M of $4.1M raised
Amount Raised
$2.82 Million
$2.82 Million sold, per SEC Form D (first sale Mar 11, 2019)
Round Type
Seed
FremontHealthcare
Quick answer
Free Flow Medical raised $2.82 Million in a Seed round, dated March 11, 2019. Free Flow Medical is based in Fremont, California, United States.
How much did Free Flow Medical raise?
Free Flow Medical raised $2.82 Million in a Seed round on March 11, 2019.
What does Free Flow Medical do?
Free Flow Medical is developing a next generation medical device technology to treat patients with late stage emphysema, an advanced form of Chronic Obstructive Pulmonary Disease (COPD) that severely limits quality of..
Where is Free Flow Medical based and how big is it?
Free Flow Medical is based in Fremont, California, United States.
Who are the decision-makers at Free Flow Medical?
Fundz holds 1 contact at Free Flow Medical. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Free Flow Medical that raised within 45 days of this round, from Fundz verified event records.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Free Flow Medical
Location
44380 S. GRIMMER BLVD.
Fremont, California, United States
About
Free Flow Medical is developing a next generation medical device technology to treat patients with late stage emphysema, an advanced form of Chronic Obstructive Pulmonary Disease (COPD) that severely limits quality of life, presents the patient with ongoing severe breathlessness and eventual mortality. COPD is the third leading cause of death in the US behind cancer and heart disease. Almost 15.7 million US adults in 2014 have been diagnosed with COPD according Centers for Disease Control and Prevention.
Free Flow Medical's founding team is led by inventor/entrepreneur, Mark Mathis. In addition to being involved in a variety of areas within the medical device field since the 1980's with over 100 us patents granted, Mark founded and built PneumRx Inc, where he invented the lung volume reduction coil implant technology that is still the only successful treatment for both heterogenous and homogeneous disease, even in patients who have been tested and found to be CV (collateral ventilation) positive and negative. In early 2015, PneumRx was acquired by BTG (British Technology Group) for $475M. Mark stayed on until late 2016 and then he founded Free Flow Medical in 2017 to develop a next generation coil technology.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Free Flow Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
FremontHealthcare